REGELTEC
REGELTEC
Social Links:
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.regeltec.com
Total Employee:
11+
Status:
Active
Contact:
(443) 451-3915
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
SyMap Medical
SyMap Medical is an innovative medical device company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Abell Foundation
Abell Foundation investment in Series A - ReGelTec
TEDCO
TEDCO investment in Venture Round - ReGelTec
Abell Foundation
Abell Foundation investment in Venture Round - ReGelTec
Official Site Inspections
http://www.regeltec.com Semrush global rank: 1.55 M Semrush visits lastest month: 16.86 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ReGelTec"
ReGelTec, Inc. | HYDRAFIL | Injectable Gel | Degenerative Discs
Injectable Gel for Degenerative Discs ReGelTec, Inc. is a clinical stage medical device company developing the next generation of interventional spinal implants for chronic lower back pain …See details»
ReGelTec - Crunchbase Company Profile & Funding
ReGelTec is a medical device company. View contacts for ReGelTec to access new leads and connect with decision-makers. ReGelTec provides Biotechnology services. A hydrogel injected …See details»
Our Team - ReGelTec
The ReGelTec team is a combination a world class academic team alongside experienced MedTech executives with prior experience guiding new technologies and companies from …See details»
ReGelTec, Inc - LinkedIn
Injectable Gel for Degenerative Disks | ReGelTec is a medical device company that is developing the next generation of minimally invasive spinal implants for lower back pain and degenerative disc...See details»
ReGelTec Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for ReGelTec. Use the PitchBook Platform to explore the full profile.See details»
ReGelTec, Inc., a Rowan Innovation Venture Fund …
ReGelTec, Inc., a medical device company developing a treatment for chronic low back pain, has received breakthrough device designation for its HYRDAFIL System from the Center for Devices and Radiological Health (CDRH) of the …See details»
Minimally Invasive Pain Treatments with ReGelTec - Tech Council …
ReGelTec is developing an injectable hydrogel for minimally invasive treatment of chronic low back pain from degenerative disc disease. Learn more at https://regeltec.comSee details»
The FDA Approves IDE for ReGelTec's Pivotal Study HYDRAFIL
Sep 28, 2023 · ReGelTec, Inc., announced that the U.S. Food and Drug Administration has approved an IDE for the company’s pivotal study to support premarket approval of its …See details»
ReGelTec - Funding, Financials, Valuation & Investors - Crunchbase
ReGelTec is funded by 2 investors. Abell Foundation and TEDCO are the most recent investors. in funding over 2 rounds. Their latest funding was raised on Oct 14, 2020 from a Series A …See details»
Peter Wilson - VP of R&D at ReGelTec, Inc - The Org
Peter Wilson brings 25+ years of experience of medical device experience to ReGelTec. Most recently, he was a co-founder and VP of R&D at Harpoon Medical where he oversaw all …See details»
ReGelTec, Inc., a Rowan Innovation Venture Fund
Dec 18, 2020 · ReGelTec, Inc., a medical device company developing a treatment for chronic low back pain, has received breakthrough device designation for its HYRDAFIL System from the Center for Devices and …See details»
Medical device startup ReGelTec raises $3.75M, reports clinical ...
Oct 15, 2020 · Baltimore medical device startup ReGelTec is conducting a trial on patients and reporting new $3.75 million in funding as it develops a treatment for chronic low back pain.See details»
The FDA Approves IDE for ReGelTec’s Pivotal Study of HYDRAFIL® …
Sep 28, 2023 · BALTIMORE-- ( BUSINESS WIRE )-- ReGelTec, Inc., announced that the U.S. Food and Drug Administration has approved an IDE for the company’s pivotal study to support …See details»
The FDA Approves IDE for ReGelTec’s Pivotal Study of HYDRAFIL® …
BALTIMORE– (BUSINESS WIRE)– ReGelTec, Inc., announced that the U.S. Food and Drug Administration has approved an IDE for the company’s pivotal study to support premarket …See details»
ReGelTec’s HYDRAFIL Technology Selected as Best ... - Business Wire
Jul 20, 2022 · ReGelTec, Inc. is a clinical stage medical device company commercializing HYDRAFILâ„¢, a percutaneous treatment for low back pain due to degenerative disc disease.See details»
Contact - ReGelTec
ClinicalTrials.gov will have up-to-date information about the status of the Company’s clinical investigations of HYDRAFIL and the acceptance requirements.See details»
ReGelTec: Implanting a Solution for Degenerative Disc Disease
By restoring vertebral disc height with an injectable, durable hydrogel, ReGelTec aims to give interventional spine and pain clinicians an effective option for one of the most common causes …See details»
ReGelTec — Latest Stories — Pain News Network
Jun 8, 2022 · ReGelTec is currently recruiting 50 people with DDD in Canada for a new clinical trial of Hydrafil. Degenerative disc disease is one of the leading causes of chronic low back …See details»
News - ReGelTec
ReGelTec, Inc., announced that the U.S. Food and Drug Administration has approved an IDE for the company’s pivotal study to support premarket approval of its HYDRAFIL® System. …See details»
Regeltec chooses Colombia and Bioaccessâ„¢ for the first-in-human ...
Bioaccessâ„¢ is a Florida-based clinical research organization (CRO) and market access consulting company which mission is to help innovative medical device companies conduct …See details»